2 results
Approved WMORecruiting
The aim of this study is to examine whether roflumilast improves cognition in clinical patients with MCI or mild dementia.
Approved WMORecruiting
Part 1:The objective is to compare the efficacy and safety of risankizumab versus ustekinumab over 48 weeks for the treatment of adult subjects with moderate to severe Crohn's Disease (CD) who have failed anti-TNF therapy.Part 2:The objective…